55 Stocks Moving In Friday's Mid-Day Session

Gainers

• Wellesley Bancorp, Inc. WEBK shares climbed 29.1% to $41.70. Cambridge Trust announced plans to acquire Wellesley Bank for $122 million.
• Cassava Sciences, Inc. SAVA shares gained 29.7% to $2.3350 after the company announced additional positive Phase 2a clinical data in Alzheimer's disease at the CTAD 2019.
• Genesco Inc. GCO gained 27.4% to $47.07 after the company reported upbeat Q3 earnings and issued strong FY20 EPS forecast.
• Big Lots, Inc. BIG rose 25.8% to $24.10 after the company reported upbeat results for its third quarter.
• KLX Energy Services Holdings, Inc. KLXE surged 24.4% to $5.26 after OPEC and OPEC+ agreed to further oil production cuts.
• Cancer Genetics, Inc. CGIX rose 22.1% to $6.73.
• Onconova Therapeutics Inc ONTX gained 20.5% to $0.3520 after the company announced it has entered into a collaboration agreement with Inceptua Medicines Access to make available intravenous rigosertib via pre-approval access program in selected countries.
• EZCORP, Inc. EZPW rose 19.5% to $6.25 following Q4 earnings.
• Sierra Oncology Inc SRRA surged 19.1% to $0.4562 after Oppenheimer initiated coverage on the company's stock with an Outperform rating and a $1.20 price target.
• Domo, Inc. DOMO rose 16.7% to $22.76 after the company reported Q3 EPS and sales results. The company also issued Q4 EPS and sales guidance above analyst estimates.
• Epizyme, Inc. EPZM gained 14.2% to $17.48 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised the price action from $12 to $22 per share.
• Clovis Oncology, Inc. CLVS gained 13.7% to $10.07 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
• The Chemours Company CC climbed 13.3% to $17.06 on reports stating the House is said to be easing 'Forever chemical' wording.
• Lexicon Pharmaceuticals, Inc. LXRX rose 12.7% to $4.77 on continued momentum after the company reported the topline Phase 1 data for its LX9211. NOTE: The study showed favorable safety results.
• Hovnanian Enterprises, Inc. HOV gained 12.7% to $28.14. Buckingham maintained Hovnanian with a Neutral and raised the price target from $24 to $27.
• PolarityTE, Inc. PTE surged 12.3% to $2.9081.
• Ulta Beauty, Inc. ULTA rose 12% to $264.34 after the company reported better-than-expected Q3 EPS results. The company also narrowed its FY19 EPS guidance above analyst estimates.
• Harpoon Therapeutics, Inc. HARP climbed 11.4% to $19.96.
• Rocket Pharmaceuticals, Inc. RCKT gained 10.4% to $21.76. Rocket Pharma reported that first patient has been treated in global registrational Phase 2 study of RP-L102 for fanconi anemia.
• Evolent Health, Inc. EVH shares climbed 10.3% to $7.37 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
• Zumiez Inc. ZUMZ rose 10.3% to $33.71 after the company reported stronger-than-expected Q3 results and issued Q4 EPS guidance above analyst estimates.
• Avadel Pharmaceuticals plc AVDL gained 10% to $6.34.
• National Beverage Corp. FIZZ climbed 9.6% to $52.89 following Q2 results.
• Progyny, Inc. PGNY gained 9.6% to $30.54.
• Puma Biotechnology, Inc. PBYI rose 8.6% to $8.08. H.C. Wainwright initiated coverage on Puma Biotechnology with a Buy rating and a $15 price target.
• The Michaels Companies, Inc. MIK gained 8.4% to $6.59.
• Signet Jewelers Limited SIG gained 8.4% to $19.40 on continued strength from Thursday's earnings report. Wells Fargo raised the price target to $16/share but said the company's core fundamental business remains 'pressured.'
• Realogy Holdings Corp. RLGY climbed 8% to $10.52 after moving back above the $10 level. Not currently seeing any company-specific news.
• Cloudera, Inc. CLDR rose 7.7% to $10.78 after the company reported upbeat quarterly earnings.
• Tantech Holdings Ltd TANH gained 7.3% to $2.20.
• Sage Therapeutics, Inc. SAGE rose 7.2% to $64.50 after falling 59.67% on Thursday. SVB Leerink upgraded Sage Therapeutics from Underperform to Market Perform.
• Kiniksa Pharmaceuticals, Ltd. KNSA rose 7.2% to $10.69. Goldman Sachs upgraded Kiniksa Pharmaceuticals from Neutral to Buy and raised the price target from $16 to $18.
• InMode Ltd. INMD gained 6.7% to $46.50 in sympathy with the overall market amid a rally in US equities following strong November jobs data.
• Adverum Biotechnologies, Inc. ADVM gained 6.7% to $11.25 in sympathy with the overall market after a rally in US equities following strong November jobs data.
• Trade Desk Inc TTD rose 5.5% to $253.68. Needham upgraded Trade Desk from Hold to Buy and announced a $325 price target.
• DocuSign, Inc. DOCU rose 4.1% to $72.36 after reporting better-than-expected Q3 earnings results.

Check out these big penny stock gainers and losers

Losers

• Correvio Pharma Corp. CORV shares dipped 33.9% to $1.4283.
• Oyster Point Pharma, Inc. OYST shares fell 16% to $15.51.
• Yext, Inc. YEXT fell 15.2% to $14.07 after the company reported worse-than-expected Q3 EPS results and issued weak forecast.
• IMAC Holdings, Inc. IMAC dropped 13.5% to $1.7296.
• Liquid Media Group Ltd. YVR dipped 13.3% to $2.55.
• ASLAN Pharmaceuticals Limited ASLN fell 10.8% to $2.22 on continued downward momentum after the company priced a 5.2 million ADS offering at $2.50 per ADS.
• Cortexyme, Inc. CRTX dropped 10.8% to $30.60.
• PagerDuty, Inc. PD shares fell 10.3% to $22.41 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 and FY20 EPS guidance below analyst estimates.
• Zoom Video Communications, Inc. ZM fell 10.3% to $62.51 after the company reported Q3 earnings results. The company also issued Q4 and FY20 guidance.
• Intercept Pharmaceuticals, Inc. ICPT dipped 10.2% to $107.54. Intercept announced publication of results from the interim analysis of the Phase 3 REGENERATE study of OCA for the treatment of fibrosis due to NASH in The Lancet.
• DarioHealth Corp DRIO fell 9.4% to $7.70.
• China Automotive Systems, Inc. CAAS fell 8.7% to $3.56.
• Eloxx Pharmaceuticals, Inc. ELOX dropped 8.4% to $5.25.
• Proteostasis Therapeutics, Inc. PTI dipped 8.2% to $3.4808.
• IDT Corporation IDT fell 8% to $6.90 following Q1 results.
• Guidewire Software Inc GWRE fell 6.4% to $111.67 after the company issued Q2 sales guidance below analyst estimates.
• Weidai Ltd. WEI fell 5% to $4.24 after declining 10.29% on Thursday.
• Ciena Corporation CIEN fell 4.7% to $34.58. UBS downgraded Ciena from Neutral to Sell and lowered the price target from $43 to $31.
• Xinyuan Real Estate Co., Ltd. XIN fell 4.4% to $3.7389 following Q3 results.